Find your next investing idea
Search discussions, company news, and communities. Try a ticker or a topic like cash flow.
Results for “cash flow” · Page 2
Discussions
Stitch Fix forecasts lower profitability despite quarterly sales growth
Stitch Fix, Inc. · Stitch Fix ($SFIX) increased fiscal fourth-quarter revenue by 4.2% to $324.4 million, but active clients declined 1.4% to 2.277 million. The company reported a $2.1 million net loss and $10.8 million in adjusted EBITDA. Its full fiscal year
Read discussion →B90 revenue rises 38% while adjusted earnings remain broadly flat
B90 Holdings plc · B90 Holdings ($B90) reported first-half revenue of €3.325 million, an increase of 38%. Adjusted EBITDA was approximately €0.31 million, compared with €0.30 million a year earlier, showing that the strong sales increase did not produce a sim
Read discussion →CRISM reports higher development spending and a £1.41 million loss
Crism Therapeutics Corporation · CRISM Therapeutics ($CRTX) reported a first-half loss of £1.413 million, compared with £0.930 million a year earlier. Administrative expenses reached £1.52 million, including £956,000 of research and development spending. Operating cash out
Read discussion →CAVA authorizes a $100 million share-repurchase program
Cava Group, Inc. · CAVA’s ($CAVA) board authorized the repurchase of up to $100 million of common stock. The program runs until September 17, 2027, and may be funded from existing cash and future operating cash flow. Purchases can take place in the market, th
Read discussion →Texas Instruments plans a 7% increase in its quarterly dividend
Texas Instruments Inc · Texas Instruments ($TXN) announced plans to increase its quarterly dividend to $1.52 per share from $1.42, a rise of approximately 7%. That would lift the annualized distribution to $6.08 per share and mark the company’s 23rd consecutive ye
Read discussion →Mothercare warns of solvency risk after franchise-store closure plans
Mothercare plc · Mothercare ($MTC-LSE) warned that its longer-term solvency is highly uncertain after its main Middle Eastern franchise partner indicated that most of its stores in the region are expected to close in 2027. The company anticipates a material
Read discussion →Fluence cuts revenue outlook and widens expected operating loss
Fluence Energy, Inc. · Fluence ($FLNC) Energy reduced its fiscal 2026 revenue forecast to approximately $2.4 billion, compared with the previous $3 billion midpoint. It now expects an adjusted EBITDA loss of about $200 million, substantially worse than the prior
Read discussion →Bilfinger lowers earnings outlook and launches €75 million restructuring
Bilfinger SE · Bilfinger ($GBF) reduced its 2026 revenue outlook to €5.3–5.7 billion from €5.4–5.9 billion and cut its expected EBITA margin to 3.2–3.6% from 5.8–6.2%. The industrial-services group said second-half performance was falling materially short
Read discussion →Aeluma reports wider annual loss as spending and cash reserves rise
Aeluma, Inc. · Aeluma ($ALMU) reported fiscal 2026 revenue of $4.5 million, compared with $4.7 million a year earlier, while its net loss widened to $9.2 million from $3 million. Fourth-quarter revenue fell to approximately $0.6 million from $1.3 million,
Read discussion →Apollo provides $1.25 billion financing tied to BMG–Concord combination
Apollo Global Management, Inc. · Apollo ($APO)-managed funds and affiliates provided a $1.25 billion capital solution supporting the combination of music businesses BMG and Concord. The transaction involves an equity investment in a BMG subsidiary holding Concord’s legacy
Read discussion →Beauty Tech raises earnings target and plans £20 million buyback
The Beauty Tech Group plc · The Beauty Tech ($TBTG) Group reported first-half revenue of £79.7 million, up 44.3%, and adjusted EBITDA of £21.3 million, up 53%. The adjusted EBITDA margin increased to 26.7%, while statutory pre-tax profit reached £17.5 million. Managem
Read discussion →Ciena targets 30% annual revenue growth through fiscal 2029
Ciena Corp · Ciena ($CIEN) set a target of approximately 30% compound annual revenue growth from fiscal 2026 through fiscal 2029. Its three-year plan also calls for an adjusted gross margin near 50%, an adjusted operating margin of 32–35%, and a free-ca
Read discussion →Unisys transfers $200 million of pension obligations to New York Life
Unisys Corp · Unisys ($UIS) transferred approximately $200 million of US defined-benefit pension obligations to New York Life through an annuity transaction covering about 1,700 retirees and beneficiaries. The purchase was funded with pension-plan assets
Read discussion →Greencoat Renewables returns to profit despite below-budget generation
Greencoat Renewables plc · Greencoat Renewables ($GRP) reported a €11.9 million first-half profit after tax, compared with a €68 million loss a year earlier. Net cash generation of €59.8 million covered dividends 1.6 times, and distributions paid or declared totaled
Read discussion →Kroger cuts sales-growth guidance but maintains earnings outlook
Kroger Co · Kroger ($KR) reduced its full-year identical-sales growth forecast, excluding fuel, to 0.2–0.8% from 1–2%. The revised range includes an approximately 1.4-percentage-point headwind from the Inflation Reduction Act. Second-quarter sales reac
Read discussion →Genus announces a £60 million buyback after stronger annual earnings
Genus PLC · Genus ($GNS-LSE) announced a £60 million share-buyback program after adjusted pre-tax profit rose 35% to £100.2 million. Revenue declined 2% to £658.1 million, but stronger profitability in its pig-genetics business and improvements in its
Read discussion →Tetra Tech adds $500 million to its share-repurchase capacity
Tetra Tech Inc · Tetra Tech’s ($TTEK) board approved an additional $500 million share-repurchase authorization, increasing available capacity to $898 million. The expansion more than doubles the amount remaining at the end of its fiscal third quarter. The c
Read discussion →Playtech’s half-year EBITDA jumps 77% on Americas growth
Playtech Plc · Playtech ($PTEC) reported first-half revenue from continuing operations of €425.1 million, up 10%, while adjusted EBITDA increased 77% to €162.5 million. Business-to-business revenue grew 14% to €394.8 million, helped by rapid expansion in
Read discussion →Axogen pairs a $200 million BioCircuit acquisition with a share offering
Axogen, Inc. · Axogen ($AXGN) agreed to acquire BioCircuit Technologies for $200 million in cash, adding the NerveTape platform for sutureless peripheral-nerve repair. The buyer expects the transaction to support revenue growth and improve adjusted EBITDA
Read discussion →Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks Holdings, Inc. · Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co
Read discussion →